Morgan Stanley’s Roundhill GLP-1 & Weight Loss ETF OZEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48K Buy
1,539
+500
+48% +$17K ﹤0.01% 6438
2025
Q4
$35.5K Hold
1,039
﹤0.01% 6535
2025
Q3
$28.4K Hold
1,039
﹤0.01% 6583
2025
Q2
$26.2K Hold
1,039
﹤0.01% 6568
2025
Q1
$24.6K Hold
1,039
﹤0.01% 6493
2024
Q4
$25.3K Hold
1,039
﹤0.01% 6500
2024
Q3
$28.7K Buy
1,039
+39
+4% +$1.08K ﹤0.01% 6388
2024
Q2
$26.6K Buy
+1,000
New +$25.8K ﹤0.01% 6369

Other funds holding OZEM

Morgan Stanley's OZEM Position: Q1 2026 in Review

Morgan Stanley increased its Roundhill GLP-1 & Weight Loss ETF (OZEM) stake by 48% in Q1 2026, buying an estimated $17K and bringing the position to 1,539 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #6438.

Morgan Stanley first reported a position in OZEM in Q2 2024 and has held it in 8 quarters since. 25 funds tracked by Wall St. Rank hold OZEM as of Q1 2026.

  • Morgan Stanley held 1,539 shares of Roundhill GLP-1 & Weight Loss ETF worth $48K as of Q1 2026.
  • Morgan Stanley bought 500 Roundhill GLP-1 & Weight Loss ETF shares in Q1 2026, an estimated $17K.
  • Roundhill GLP-1 & Weight Loss ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6438 holding.
  • Morgan Stanley first reported a position in Roundhill GLP-1 & Weight Loss ETF in Q2 2024 and has held it in 8 quarters since.
  • 25 funds tracked by Wall St. Rank held Roundhill GLP-1 & Weight Loss ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.